Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
about
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's diseaseDifferentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease.Voxel-based morphometry in autopsy proven PSP and CBDGray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies.The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.Transcranial brain sonography findings in two main variants of progressive supranuclear palsy.Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study.In vivo evaluation of white matter pathology in patients of progressive supranuclear palsy using TBSS.Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy.Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: clinicopathological case.MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's diseaseCharacterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathyVariation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
P2860
Q24597126-12AE48A5-DFC4-49F8-8C46-24CD8561167DQ30588544-7CC90080-6621-4011-9346-3114833889F1Q34405999-B7535D5D-0AC0-42A4-9762-B2A86E536883Q34767058-F7D00A92-0CFE-42DE-90A8-575085845C83Q36176200-19B8CEE1-301C-4988-B871-2401B370D028Q37243463-2E25D498-1EEE-4D2B-8022-AFE8B49C49AEQ38094660-757C02AC-5F80-42DD-9986-AFF1CC7FE933Q38265061-4D62E180-86C3-41DD-8C90-3B0F12EEF1E9Q48283959-4D8C80DF-319B-4C66-9ED4-45BF6F7A8BFAQ50640064-B134F4A3-BBAF-419E-ACA5-838BD604A8F0Q50776691-B35EE4B6-8EE3-45E4-8091-478CA7025E6BQ51736398-63B8BEBB-EF0C-4F08-9FA8-C348B02FD1ECQ51874272-AA62BE34-EA6F-4466-8259-A6E4BA586F00Q57911761-5F5B5C4E-1CC9-4516-878E-441C8A3C2BF5Q58008864-922706B6-7BFE-49A1-AF17-FFC246F64AC2Q59133037-148A261A-378E-4AE2-BDD5-55EE4B4C44DA
P2860
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@ast
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@en
type
label
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@ast
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@en
prefLabel
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@ast
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@en
P2093
P2860
P356
P1433
P1476
Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy.
@en
P2093
Anderton BH
Katzenschlager R
P2860
P304
P356
10.1093/BRAIN/AWF109
P407
P577
2002-05-01T00:00:00Z